Bioactive fluorenes. part I. Synthesis, pharmacological study and molecular docking of novel dihydrofolate reductase inhibitors based-2,7-dichlorofluorene

Add time:07/11/2019    Source:sciencedirect.com

In this study, a new series of 2,7-dichloro-4-(2-substituted-amino acetyl)fluorene derivatives were synthesized, characterized and evaluated for their antimicrobial activity and screened for cytotoxic activity against human lung carcinoma (A-549) and human breast carcinoma (MCF-7) cell lines. Most of the synthesized compounds displayed significant activity against A-549 and MCF-7 cell lines when compared to 5-fluorouracil (5-FU), which was used as a reference drug. In addition, some of these reported novel compounds exhibited promising antibacterial and antifungal properties. A molecular docking study was performed to identify the mechanism of action of the synthesized compounds, which suggested binding interactions with the active sites of dihydrofolate reductase (DHFR).

We also recommend Trading Suppliers and Manufacturers of 4-CHLOROACETYL-2,7-DICHLOROFLUORENE (cas 131023-37-5). Pls Click Website Link as below: cas 131023-37-5 suppliers

Prev:Ab initio Hartree–Fock and density functional theory investigations on the conformational stability, molecular structure and vibrational spectra of 3-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)benzo[d]thiazol-2(3H)-one
Next:Co-catalytic cracking of n-decane and 2-Ethylphenol (cas 90-00-6) over a variety of deactivated zeolites for the conversion of fossil- and bio-based feeds in Co-FCC)